Venture Fund Member Profile
|
 |
 |
CMEA Capital is a venture capital firm with a clear focus on life sciences, high technology, and energy and materials investments. We believe that the most successful venture backed companies are those that are science based, with experienced teams that have a vision. As a result, CMEA typically invests in companies that have cutting edge and highly differentiated technology at their core and founding teams of the highest caliber still in place. These are companies that have the potential to transform their industries.
CMEA Capital was founded in 1989 and maintains offices in San Francisco and Menlo Park. We invest in both early and late stage science-focused ventures, and leverage a strong network of corporate, investment, and entrepreneurial relationships on behalf of portfolio companies. Our partners and associates have extensive science, engineering, and operational backgrounds, providing us the confidence to look beyond today’s technology. We apply our focus on science and teams to our collaborations with entrepreneurs and venture investment partners who are changing the world, one great company at a time.
 |
Erik Sebusch
Partner
CMEA Capital |
Erik Sebusch has no doubts about who's at "the top of the food chain" in the world of venture capital – the Limited Partner. CMEA Capital's newest partner is committed to giving LPs the attention and communications they need.
With deep experience on the investment side, Erik understands the evolving needs of limited partners. They have more investment opportunities to choose from. They're looking more closely at risk-return tradeoffs. And they're demanding greater transparency and communications. Erik's role is to give them all of the above. "Our goal is to develop a best-in-class platform on which we can communicate with our limited partners and build strong strategic relationships," Erik said.
Erik is a “trained innovator,” which means he does not easily accept the status quo. During his long career at UPS, which he calls a “left-brained organization,” Erik encouraged them to use “right brain thinking” to develop new products while in New Product Concepts. This innovation continued while in UPS’s venture arm, UPS Strategic Enterprise Fund. Erik was involved in assisting and strategizing with early-stage startups to get their message and technology exposed to UPS and out to the world.
Erik has life-long interest in technologies involving personal and national security. Since 911, that interest has taken on a higher purpose – helping to keep America safe. He sits on the Department of Homeland Security’s pilot program, the SouthEast Emergency Response Network and takes part in the American Security Challenge. The latter is a private-sector competition that supports the development of security technologies. One recent standout is a high performance “panoramic” visual reality goggle, developed by Sensics. It’s used to train personnel in armored vehicles, flight simulators and combat.
Erik will bring a similar panoramic vision to our relations with limited partners and strategic partnerships
Representative Investments
 |
Schooner Information Technology provides high-availability MySQL and NoSQL software distributions for demanding mission-critical applications. Schooner software offers high-performance replication which guarantees no data loss, provides instant automated failover and recovery, and simplifies cluster administration. Schooner's high performance enables dramatic server consolidation and reduced sharding, allowing datacenters to handle bigger loads with fewer nodes. Customers rely on Schooner to slash the downtime that costs revenue, customers and reputation, and to save substantially on server capex and the power, pipe, and people to run them. |
 |
Foro Energy delivers the performance of high power lasers to meet the world's growing energy demands. |
 |
Bayhill Therapeutics Bayhill Therapeutics is a clinical-stage biopharmaceutical company at the forefront of developing novel and targeted treatment candidates for autoimmune diseases. Leveraging its proprietary therapeutic BHT-DNA™ platform, the Company’s product candidates are designed to restore patient’s immunological “tolerance” to self antigens to a normal state by selectively eliminating specific, harmful immune responses while leaving the rest of the immune system intact. Through a targeted and selective approach, Bayhill’s product candidates have the potential to deliver superior efficacy, safety and tolerability relative to current therapies. |
 |
NuScale Power is helping to meet the need for clean energy through the development of a modular, scalable, inherently safe nuclear power plant, with all equipment manufactured in the US. |
Erik participated in the FundingPost event: Atlanta VC and Angel Event
on Thursday, March 1, 2012 in GA, Sponsored by Chamber of Eco Commerce
To list your Company on our website and make your profile available to Erik and 7,500+ other VCs and Angel Investors, Click Here.
============================================
About FundingPost
For over Twelve Years FundingPost has worked with thousands
of Angel and Venture Capital Investors. We believe that it is
important to reach investors in every medium possible -
both online and offline. We have been directly responsible for
tons of success stories and Millions and Millions of dollars raised.
We look forward to introducing your company to the leading Venture and Angel Investors nationwide.
============================================
|
| Venture Fund Member Profile |
|
Bookmark to del.icio.us
Tweet this Profile
